binge eating disorder glp 1 Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Disorder: A Narrative Review GLP-1 Agonist for Binge Eating
Description
Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines
Leptin and ghrelin recalibration Leptin, the satiety hormone produced by fat cells, decreases as you lose weight
3 : e1709
In clinical studies, people using tirzepatide alongside nutrition and activity changes often achieved greater average weight loss than those using several other weight-loss medications, including some GLP-1only treatments, though individual results can vary
Sublingual doses need to be higher than injectable doses to account for lower bioavailability
Previous presentation: These data were presented in part as a poster at the Annual Meeting of the Endocrine Society
